Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620373 · ClinicalTrials.gov registry record · NA
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 969
- Enrollment target
NCT00620373: Completed NA study, sponsored by Mayo Clinic.
NCT00620373 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 969 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00620373, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 969 participants
- Enrollment target
Study Summary
We aim to compare the sensitivity of mammography to the sensitivity of Molecular Breast Imaging (a new gamma-camera based breast imaging technology) in women with dense breast tissue who are at increased risk for breast cancer.
Interventions
- DEVICE Molecular Breast Imaging
- DEVICE Conventional Mammography
- DRUG Technetium (99mTc) sestamibi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 969 participants |
| Start Date | 2005-08 |
| Est. Completion | 2010-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00620373
The ClinicalTrials.gov registry entry for NCT00620373 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 969 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Molecular Breast Imaging is the first listed.
NCT00620373 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00620373 about?
NCT00620373 is a clinical study titled "Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts". We aim to compare the sensitivity of mammography to the sensitivity of Molecular Breast Imaging (a new gamma-camera based breast imaging technology) in women with dense breast tissue who are at increased risk for breast cancer.
What is the current status of trial NCT00620373?
This trial is currently completed. It is a NA study. The enrollment target is 969 participants. The study started on 2005-08. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00620373?
The interventions under investigation include: Molecular Breast Imaging (DEVICE), Conventional Mammography (DEVICE), Technetium (99mTc) sestamibi (DRUG).
Who is sponsoring clinical trial NCT00620373?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.